000 01752 a2200529 4500
005 20250515235151.0
264 0 _c20101112
008 201011s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/leu.2010.163
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPardanani, A
245 0 0 _aLNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations.
_h[electronic resource]
260 _bLeukemia
_cOct 2010
300 _a1713-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdaptor Proteins, Signal Transducing
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBlast Crisis
_xgenetics
650 0 4 _aChronic Disease
650 0 4 _aDNA, Neoplasm
_xgenetics
650 0 4 _aDNA-Binding Proteins
_xgenetics
650 0 4 _aDioxygenases
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIntracellular Signaling Peptides and Proteins
650 0 4 _aIsocitrate Dehydrogenase
_xgenetics
650 0 4 _aJanus Kinase 2
_xgenetics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMutation
_xgenetics
650 0 4 _aMyeloproliferative Disorders
_xgenetics
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aPrognosis
650 0 4 _aProteins
_xgenetics
650 0 4 _aProto-Oncogene Proteins
_xgenetics
650 0 4 _aReceptors, Thrombopoietin
_xgenetics
700 1 _aLasho, T
700 1 _aFinke, C
700 1 _aOh, S T
700 1 _aGotlib, J
700 1 _aTefferi, A
773 0 _tLeukemia
_gvol. 24
_gno. 10
_gp. 1713-8
856 4 0 _uhttps://doi.org/10.1038/leu.2010.163
_zAvailable from publisher's website
999 _c20060612
_d20060612